Skip to main content
. 2014 Jul 28;15(9):3328–3337. doi: 10.1021/bm500809f

Figure 3.

Figure 3

Effect of administering varying concentrations of 5000 Mw (A) and 2000 Mw (B) ether-AMs (dark gray) and alkyl-AM analogues (light gray) on percent of oxLDL uptake in HMDMs. AMs of specific alkyl lengths are grouped between the dashed lines, and the AM treatments not investigated due to cytotoxicity issues are indicated as text on the graph. Significant deviations from the oxLDL positive control (black) are denoted by asterisks (∗) on the graph.